Beam Therapeutics

DNA strand gene editing
Biotech

Beam hits hemoglobin goal in first base editing clinical data

All four sickle cell patients had fetal hemoglobin levels above Beam’s target but one patient died, likely as a result of the conditioning regimen.
Nick Paul Taylor Nov 5, 2024 9:00am
Graphic of three faceless profiles aimed diagonally to the right with two check marks in between them Orange background

Third Rock adds 3 new venture partners, including Karuna’s Paul

Jan 25, 2024 10:35am
Beam alien spacecraft UFO halloween

Beam offloads Verve rights to Lilly for up to $600M

Oct 31, 2023 6:00am
layoff workforce cuts reduction stock

Beam lays off 20% of staff and culls CAR-T work to save cash

Oct 19, 2023 11:00am
A silver slightly shiny strands of DNA appear against a background of clocks

Beam aims to dose first patient in sickle cell trial this year

Aug 8, 2023 4:10pm
Graphic image of someone plucking out a portion of DNA with tweezers symbolizing gene editors

Peter Marks: Gene editing has met regulatory reality

Jul 31, 2023 3:14pm